Advertisement

Journal of Gastroenterology

, Volume 45, Issue 6, pp 636–645 | Cite as

Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community

  • Kuo-Chin Chang
  • Pei-Shan Tsai
  • Mei-Chin Hsu
  • Shu-Fen Hung
  • Chin-Chen Tsai
  • Sheng-Nan LuEmail author
Original Article—Liver, Pancreas, and Biliary Tract

Abstract

Background

To elucidate the factors associated with mortality rates among older subjects with hepatocellular carcinoma (HCC) and diabetes mellitus (DM) in a triple hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis delta virus (HDV) endemic community.

Methods

A total of 2,909 residents aged ≥45 years were screened for hepatitis B surface antigen (HBsAg), antibodies to HCV (anti-HCV) and alanine aminotransaminase (ALT) in 1997. Anti-HDV was detected in HBsAg-positive subjects. Those who expired from HCC and DM were identified from official mortality data sets (1997–2003). Survival was analyzed using the Kaplan–Meier survival curve with log-rank test and the Cox proportional hazard model.

Results

Forty-one patients died of HCC and 25 of DM during the study period. Multivariate analysis indicated that age ≥65 years (hazard ratio 3.4; 95% confidence interval 1.8–6.4), HBsAg (3.3; 1.7–6.7), anti-HCV (3.8; 1.7–8.5) and ALT ≥40 IU/L (3.7; 1.9–7.0) were independent predictors of HCC mortality, while age ≥65 years (4.8; 2.1–11.0) and anti-HCV (4.2; 1.7–10.6) were two independent predictors of DM mortality. There were synergistic effects of dual viral infections for HCC, but not for DM mortality.

Conclusions

Old age and chronic HCV infection increase the risk of HCC and DM mortality. HBsAg and ALT levels are also risk factors for HCC mortality, but not DM. The synergistic effects of dual hepatitis viral infections are demonstrable and warrant further investigation.

Keywords

Diabetes mellitus Hepatitis B virus Hepatitis C virus Hepatocellular carcinoma Mortality 

Notes

Acknowledgments

This study was supported by a grant to Dr. S.N. Lu from the National Science Council of the Republic of China (NSC 92-2314-B-182-065).

References

  1. 1.
    Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–33.CrossRefPubMedGoogle Scholar
  2. 2.
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–50.CrossRefPubMedGoogle Scholar
  4. 4.
    Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, et al. Secular trends and geographic variations of hepatitis B and hepatitis C virus-associated hepatocellular carcinoma. Int J Cancer. 2006;119:1946–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Oyunsuren T, Kurbanov F, Tanaka Y, Elkady A, Sanduijav R, Khajidsuren O, et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B and delta viruses. J Med Virol. 2006;78:1688–95.CrossRefPubMedGoogle Scholar
  6. 6.
    Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. J Viral Hepat 2007;14:667–74.Google Scholar
  7. 7.
    Wu JC. Functional and clinical significance of hepatitis D virus genotype II infection. Curr Top Microbiol Immunol. 2006;307:173–86.CrossRefPubMedGoogle Scholar
  8. 8.
    Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, et al. Coinfection of hepatitis C virus in patients with hepatitis B infection. J Hepatol. 1994;21:159–66.CrossRefPubMedGoogle Scholar
  9. 9.
    Liaw YF, Tsai JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology. 1994;106:1048–53.PubMedGoogle Scholar
  10. 10.
    Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol. 1991;12:70–4.CrossRefPubMedGoogle Scholar
  11. 11.
    Tzonou A, Trichopoulos D, Kaklamani E, Zavitsanos X, Koumantaki Y, Hsieh CC. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D virus, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer. 1991;49:377–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Lu SN, Lee CM, Changchien CS, Chen CJ. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg. 1999;93:600–2.CrossRefPubMedGoogle Scholar
  13. 13.
    Osella AR, Misciagna G, Guerra VM, Chiloiro M, Cuppone R, Cavallini A, et al. Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. Int J Epideminol. 2000;29:922–7.CrossRefGoogle Scholar
  14. 14.
    Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, et al. The role of hepatitis B and C virus in hepatocellular carcinoma in a hepatitis B endemic area: a case-control study. Cancer. 1992;69:2052–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, et al. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case-control study in Italy. Hepatology. 1997;26:579–84.CrossRefPubMedGoogle Scholar
  16. 16.
    Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut. 1999;45:284–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994;74:2442–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serga HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127:1372–80.CrossRefPubMedGoogle Scholar
  19. 19.
    Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168–74.CrossRefPubMedGoogle Scholar
  20. 20.
    Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev. 1996;5:173–8.PubMedGoogle Scholar
  21. 21.
    Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol. 2007;166:196–203.CrossRefPubMedGoogle Scholar
  23. 23.
    Huang JF, Dai CY, Hwang SJ, Ho CK, Hsiao PJ, Hsieh MY, et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol. 2007;102:1237–43.CrossRefPubMedGoogle Scholar
  24. 24.
    Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;30:1059–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Admi HO, Chow WH, Nyrén O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996;88:1472–7.CrossRefGoogle Scholar
  27. 27.
    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54:533–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;44:1408–10.CrossRefGoogle Scholar
  29. 29.
    Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis virus (B, C, D) endemic community in Taiwan. J Med Virol. 2003;70:74–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Taiwan Public Health Association. Taiwan Cancer Registry. Taipei: Taiwan Public Health Association. Available at: http://crs.cph.ntu.edu.tw/. Accessed 26 Feb 2007.
  31. 31.
    Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters RL. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 1971;75:687–91.PubMedGoogle Scholar
  32. 32.
    Cheng DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990;162:817–22.Google Scholar
  33. 33.
    Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology. 1994;106:1596–602.PubMedGoogle Scholar
  34. 34.
    Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887–91.CrossRefPubMedGoogle Scholar
  35. 35.
    Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tasi YT, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology. 1991;13:830–3.CrossRefPubMedGoogle Scholar
  36. 36.
    Huang JF, Lu SN, Chue PY, Lee CM, Yu ML, Chuang WL, et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect. 2001;127:485–92.CrossRefPubMedGoogle Scholar
  37. 37.
    Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, Chuang WL, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J. 1998;17:142–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a prospective on the long-term outcome. Semin Liver Dis. 2000;20:17–35.CrossRefPubMedGoogle Scholar
  39. 39.
    Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg. 2004;98:367–72.CrossRefPubMedGoogle Scholar
  40. 40.
    Lin DB, Tsai TP, Chen WK. Seroprevalence of hepatitis C virus infection and its association with natural infection of hepatitis B virus among preschool children in Taiwan. Eur J Epidemiol. 2003;18:245–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol. 2001;65:30–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Ho MS, Hsu CP, Yuh Y, King CC, Tsai JF, Mau YC, et al. High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena? J Med Virol. 1997;52:370–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Huang CF, Huang JF, Dai CY, Yu ML, Lu SN, Hsieh MY, et al. Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan. Trans R Soc Trop Med Hyg. 2008;102:929–34.CrossRefPubMedGoogle Scholar
  44. 44.
    Lu SN, Chue PY, Chen IL, Wang JH, Huang JF, Peng CF, et al. Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci. 1997;13:605–8.PubMedGoogle Scholar
  45. 45.
    Lu SN, Lee CM, Changchien CS, Chen CJ. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg. 1999;93:600–2.CrossRefPubMedGoogle Scholar
  46. 46.
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 1992;327:1899–905.PubMedCrossRefGoogle Scholar
  47. 47.
    Lu SN, Wang JH, Kuo YK, Kuo HL, Chen TM, Tung HD, et al. Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: a method to identify areas endemic for HCV. Am J Trop Med Hyg. 2002;67:145–50.PubMedGoogle Scholar
  48. 48.
    Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106:148–55.CrossRefPubMedGoogle Scholar
  49. 49.
    Rosina F, Conoscitore P, Cuppone R, Rocca G, Giuliani A, Cozzolongo R, et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology. 1999;117:161–6.CrossRefPubMedGoogle Scholar
  50. 50.
    Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology. 2004;126:1024–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol. 2000;32:209–17.CrossRefPubMedGoogle Scholar
  52. 52.
    Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 1995;19:846–50.PubMedGoogle Scholar
  53. 53.
    Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 1998;29:198–206.CrossRefPubMedGoogle Scholar
  54. 54.
    Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci. 1996;32:526–30.PubMedGoogle Scholar
  55. 55.
    Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL, et al. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis. 2009;64:124–30.CrossRefPubMedGoogle Scholar
  56. 56.
    Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F. EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med. 2009;103:309–16.CrossRefPubMedGoogle Scholar
  57. 57.
    Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999;13:349–55.CrossRefPubMedGoogle Scholar
  58. 58.
    Chen IL, Lu SN, Wu CL. HBsAg and anti-HCV prevalence among villages in an endemic township: a community study in Tzukuan, Kaohsiung. Chin J Public Health. 1999;18:313–8.Google Scholar
  59. 59.
    Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, et al. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemia townships in Taiwan. J Gastroenterol Hepatol. 1997;12:547–50.CrossRefPubMedGoogle Scholar
  60. 60.
    Lu TH, Shau WY, Shih TP, Lee MC, Chou MC, Lin CK. Factors associated with errors in death certificate completion. A national study in Taiwan. J Clin Epidemiol. 2001;54:232–8.CrossRefPubMedGoogle Scholar
  61. 61.
    Kiehl AK, Gau DW. Death certificarion by British doctors: a demographic analysis. J Epidemiol Community Health. 1982;36:146–9.CrossRefGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Kuo-Chin Chang
    • 1
  • Pei-Shan Tsai
    • 2
  • Mei-Chin Hsu
    • 1
  • Shu-Fen Hung
    • 1
  • Chin-Chen Tsai
    • 2
  • Sheng-Nan Lu
    • 1
    Email author
  1. 1.Division of Hepato-Gastroenterology, Department of Internal MedicineChang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of MedicineKaohsiungTaiwan
  2. 2.Health Center of Zihkuan TownshipKaohsiungTaiwan

Personalised recommendations